These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25359383)
1. Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome. Cousins L; Pericleous C; Khamashta M; Bertolaccini ML; Ioannou Y; Giles I; Rahman A Ann Rheum Dis; 2015 Jan; 74(1):317-9. PubMed ID: 25359383 [No Abstract] [Full Text] [Related]
3. The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review. Meijide H; Sciascia S; Sanna G; Khamashta MA; Bertolaccini ML Autoimmun Rev; 2013 Jan; 12(3):421-5. PubMed ID: 22951216 [TBL] [Abstract][Full Text] [Related]
4. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients. Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301 [TBL] [Abstract][Full Text] [Related]
5. Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology. Martínez-Flores JA; Serrano M; Pérez D; Lora D; Paz-Artal E; Morales JM; Serrano A J Immunol Methods; 2015 Jul; 422():51-8. PubMed ID: 25865263 [TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies: lessons from the bench. Koike T; Bohgaki M; Amengual O; Atsumi T J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus]. Romicka AM; Gazda A; Zabek J; Wojciechowska B Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365 [No Abstract] [Full Text] [Related]
9. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome. Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877 [TBL] [Abstract][Full Text] [Related]
11. The antiphospholipid/cofactor syndrome: results of routine screening for antibodies to beta2-GPI upon suspicion of the antiphospholipid syndrome. Damoiseaux J; Wijffels M; Willems GM; Bevers EM; Spaanderman ME; van Pampus EC; Tervaert JW Scand J Rheumatol; 2004; 33(6):441-2. PubMed ID: 15794208 [No Abstract] [Full Text] [Related]
12. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis. Capozzi A; Riitano G; Mancuso S; Recalchi S; Manganelli V; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Truglia S; Sorice M Clin Exp Immunol; 2021 Sep; 205(3):326-332. PubMed ID: 34107056 [TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome: critical analysis of the diagnostic path. Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982 [TBL] [Abstract][Full Text] [Related]
14. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance. Selva-O'Callaghan A; Ordi-Ros J; Monegal-Ferran F; Martinez N; Cortes-Hernandez F; Vilardell-Tarres M Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576 [TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus. Demir S; Li J; Magder LS; Petri M Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921 [TBL] [Abstract][Full Text] [Related]
16. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889 [TBL] [Abstract][Full Text] [Related]
17. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome. Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess. Pérez D; Tincani A; Serrano M; Shoenfeld Y; Serrano A Lupus; 2018 Feb; 27(2):177-178. PubMed ID: 29067871 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels. Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204 [TBL] [Abstract][Full Text] [Related]
20. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus]. Borodin AG; Baranov NG; Nasonov EL Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]